Adriano Massuda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adriano massuda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adriano Massuda Today - Breaking & Trending Today

​​Financing Primary Care​

​​Session six of the PHC interest group’s ten-part seminar series “Primary Health Care: The heart of every health system” that is running once a month throughout the 2022/23 academic year.   ​The seminar series provides an overview of the key functions and features of PHC; its potential in achieving universal health coverage and its role in global health. Seminars are led by speakers working in a range of settings.  ....

United Kingdom , Luke Allen , Martin Roland , Adriano Massuda , Luisa Pettigrew , Josephine Exley , Kara Hanson , Brazilian Ministry Of Health , Professor Of Health Services Research , Professor Of Health System Economics , Cambridge Centre For Health Services Research , University Of Cambridge , Harvard School Of Public Health , Pan American Health Organization , Health Care , Vargas School Of Business Administration , Health System , Lancet Global Health Commission , Financing Primary Health , Emeritus Professor , Health Services Research , Cambridge Centre , Health Services , Vargas School , Deputy Secretary , Strategic Inputs ,

INSIGHT-The man behind Brazil's search for miracle COVID-19 cures


11 Min Read
RIO DE JANEIRO, May 14 (Reuters) - Brazilian President Jair Bolsonaro, addressing the nation last month in a social media video, touted the latest in a string of unconventional drugs he says can ease the country’s COVID-19 crisis.
Bolsonaro - a vaccine skeptic and promoter of discredited treatments such as hydroxychloroquine - said this new drug, Proxalutamide, would “soon be available to all Brazil.” He invited a little-known Health Ministry official, Helio Angotti, to expand on its promise.
Angotti, an eye doctor with no epidemiological experience, cited a domestic Proxalutamide study showing a 92% decrease in mortality risk among hospitalized COVID-19 patients. It was a dramatic claim amid a global struggle to find effective treatments. He said he aimed to “get it to the Brazilian population as soon as possible.” ....

Sao Paulo , Estado De Pernambuco , United States , Brian Thevenot , Fiocruz Amaz , Adriano Massuda , Alexandre Cavalcanti , Ricardo Zimerman , Gabriel Stargardter , Carlos Wambier , Felipe Naveca , Jair Bolsonaro , Thomson Reuters Trust Principles , Sao Paulo Hcor Research Institute , Health Ministry , University Of Pernambuco , Health Ministry Science , Brown University , Brazil Federal Council Of Medicine , President Jair Bolsonaro , Helio Angotti , Research Institute , New England Journal , Brazilian Proxalutamide , Strategic Inputs , Like Bolsonaro ,

The man behind Brazil's search for miracle COVID-19 cures


11 Min Read
RIO DE JANEIRO (Reuters) -Brazilian President Jair Bolsonaro, addressing the nation last month in a social media video, touted the latest in a string of unconventional drugs he says can ease the country’s COVID-19 crisis.
Helio Angotti Neto, chief of the Health Ministry s Science, Technology, Innovation and Strategic Inputs department attends a news conference in Brasilia, Brazil June 27, 2020. Carolina Antunes/Brazilian Presidency via REUTERS
Bolsonaro - a vaccine skeptic and promoter of discredited treatments such as hydroxychloroquine - said this new drug, Proxalutamide, would “soon be available to all Brazil.” He invited a little-known Health Ministry official, Helio Angotti, to expand on its promise. ....

Sao Paulo , Estado De Pernambuco , United States , Brian Thevenot , Fiocruz Amaz , Adriano Massuda , Alexandre Cavalcanti , Ricardo Zimerman , Gabriel Stargardter , Carlos Wambier , Felipe Naveca , Jair Bolsonaro , Thomson Reuters Trust Principles , Sao Paulo Hcor Research Institute , Health Ministry , University Of Pernambuco , Health Ministry Science , Brown University , Brazil Federal Council Of Medicine , President Jair Bolsonaro , Helio Angotti , Research Institute , New England Journal , Brazilian Proxalutamide , Strategic Inputs , Like Bolsonaro ,